{"id":"W2784438562","doi":"10.1016/j.kisu.2017.10.010","title":"Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project","year":2018,"lang":"en","type":"review","venue":"Kidney International Supplements","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University of British Columbia; St. Michael's Hospital; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Sandoz; Sanofi Australia; Amgen; Hospira; International Society of Nephrology; Baxter Healthcare Corporation; Fresenius Medical Care North America; Shire; AstraZeneca; Baxter International; GlaxoSmithKline; Genentech; Department of Biotechnology, Ministry of Science and Technology, India; National Institutes of Health; Medtronic; AbbVie; Abbott Laboratories","keywords":"Medicine; Kidney disease; Health care; Developing country; Global health; Population; Environmental health; Family medicine; Public health; Intensive care medicine; Internal medicine; Economic growth; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003427674,0.0006466831,0.001411684,0.0002251872,0.0002332004,0.0001123361,0.001317609,0.0001650391,0.0005995581],"category_scores_gemma":[0.004161566,0.0004139327,0.0002827398,0.0008744731,0.0003377156,0.0002354241,0.0009718281,0.0002324373,0.00003880967],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001888082,"about_ca_system_score_gemma":0.0190467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001482447,"about_ca_topic_score_gemma":0.00007394463,"domain_scores_codex":[0.9954467,0.0001556428,0.001264008,0.001003855,0.001473384,0.0006564432],"domain_scores_gemma":[0.9952102,0.0001112479,0.0009128558,0.0008886597,0.0003920333,0.002485012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000164422,0.0004665346,0.1813849,0.004129628,0.001117593,0.000003175279,0.00005420019,2.455467e-8,8.092009e-9,0.0002360566,0.7670785,0.04536493],"study_design_scores_gemma":[0.002610748,0.0003689403,0.01070827,0.02217506,0.0008228263,0.00000297455,0.0000613563,0.000003737666,4.898901e-7,0.0003137685,0.9626122,0.0003196538],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003562769,0.6481335,0.0001173013,0.08156245,0.001009266,0.007488932,0.2608158,0.0002212508,0.0002952465],"genre_scores_gemma":[0.0006714035,0.8803569,0.001023908,0.03191274,0.0003371656,0.0008767666,0.08466291,0.00006834023,0.0000898682],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2322234,"threshold_uncertainty_score":0.9998313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03187094360162396,"score_gpt":0.3920909163257212,"score_spread":0.3602199727240973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}